This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: General pharmacology, Subject name: Pharmacology
Secukinumab is 
Select and explain. 
A. Anti IL 1, B. Anti IL 6, C. Anti IL 17, D. Anti IL 23
C: Anti IL 17
Answer: C: Anti IL 17 
Explanation: Ustekinumab (anti-IL-12/23) and secukinumab (anti-IL-17) monoclonal antibodies have shown promising efficacy in clinical trials, but have not yet been approved for use in Ankylosing Spondylitis. Reference: Harrison&;s Principles of Internal Medicine; kd tripathi 9th ed